Communicating the Value of Pharmacodynamic Modelling in Drug ...
Communicating the Value of Pharmacodynamic Modelling in Drug ...
Communicating the Value of Pharmacodynamic Modelling in Drug ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Model-Based <strong>Drug</strong> Development<br />
Key Considerations<br />
Goal<br />
● Tools for computer assisted trial simulation<br />
● Data repositories<br />
● Standardization <strong>of</strong> tools, databases and practices<br />
● <strong>Communicat<strong>in</strong>g</strong> outcomes to decision-makers<br />
● SMALLER NUMBER OF FAILED TRIALS<br />
• Reduced cost associated with trials<br />
• Increased certa<strong>in</strong>ty <strong>in</strong> trial designs<br />
• Lower rate <strong>of</strong> late-stage attrition<br />
• Studies <strong>in</strong> appropriate populations<br />
slide 6<br />
30 May 2008, ARCS<br />
© Pharsight Corporation All Rights Reserved